LBX Pharmacy Chain JSC
SSE:603883

Watchlist Manager
LBX Pharmacy Chain JSC Logo
LBX Pharmacy Chain JSC
SSE:603883
Watchlist
Price: 17.29 CNY -0.92% Market Closed
Market Cap: 13.1B CNY
Have any thoughts about
LBX Pharmacy Chain JSC?
Write Note

LBX Pharmacy Chain JSC
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LBX Pharmacy Chain JSC
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
LBX Pharmacy Chain JSC
SSE:603883
Income from Continuing Operations
ÂĄ1.1B
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
N/A
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Income from Continuing Operations
ÂĄ977.8m
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Income from Continuing Operations
ÂĄ1.7B
CAGR 3-Years
19%
CAGR 5-Years
23%
CAGR 10-Years
N/A
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Income from Continuing Operations
ÂĄ140m
CAGR 3-Years
-14%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Income from Continuing Operations
ÂĄ175.3m
CAGR 3-Years
-43%
CAGR 5-Years
-21%
CAGR 10-Years
-5%
A
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Income from Continuing Operations
ÂĄ117.7m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

LBX Pharmacy Chain JSC
Glance View

Market Cap
13.1B CNY
Industry
Retail

LBX Pharmacy Chain JSC engages in the sale of medicine and health products. The company is headquartered in Changsha, Hunan and currently employs 29,164 full-time employees. The company went IPO on 2015-04-23. The firm involves in retailing drugs and other related products, including Chinese and Western medicines, prepared slices of Chinese crude drugs, health Chinese medicines, health equipment, healthy food, personal care products and life care products, among others. The firm also involves in wholesale and manufacture of drugs.

Intrinsic Value
51.23 CNY
Undervaluation 66%
Intrinsic Value
Price

See Also

What is LBX Pharmacy Chain JSC's Income from Continuing Operations?
Income from Continuing Operations
1.1B CNY

Based on the financial report for Jun 30, 2024, LBX Pharmacy Chain JSC's Income from Continuing Operations amounts to 1.1B CNY.

What is LBX Pharmacy Chain JSC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
14%

Over the last year, the Income from Continuing Operations growth was 4%. The average annual Income from Continuing Operations growth rates for LBX Pharmacy Chain JSC have been 10% over the past three years , 14% over the past five years .

Back to Top